Cargando…

Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis

Ursolic acid (UA) is a triterpene with a broad array of pharmacological activities. In leishmaniasis, UA killed different species of parasites, and it was active in the experimental model of cutaneous and visceral leishmaniasis. Thus, the objective of this work was to study the therapeutic efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jesus, Jéssica Adriana, Fragoso da Silva, Thays Nicolli, Yamamoto, Eduardo Seiji, G. Lago, João Henrique, Dalastra Laurenti, Márcia, Passero, Luiz Felipe Domingues
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589377/ https://www.ncbi.nlm.nih.gov/pubmed/33092305 http://dx.doi.org/10.3390/pathogens9100855

Ejemplares similares

Preclinical Assessment of Ursolic Acid Loaded into Nanostructured Lipid Carriers in Experimental Visceral Leishmaniasis
por: Jesus, Jéssica Adriana, et al.
Publicado: (2021)

Therapeutic effect of ursolic acid in experimental visceral leishmaniasis
por: Jesus, Jéssica A., et al.
Publicado: (2016)

Related Pentacyclic Triterpenes Have Immunomodulatory Activity in Chronic Experimental Visceral Leishmaniasis
por: de Jesus, Jéssica Adriana, et al.
Publicado: (2021)

Antimicrobial Activity of Oleanolic and Ursolic Acids: An Update
por: Jesus, Jéssica A., et al.
Publicado: (2015)

Corrigendum to “Therapeutic effect of ursolic acid in experimental visceral leishmaniasis” [Int. J. Parasitol. Drugs Drug Resist. 7 (2017) 1–11]
por: Jesus, Jessica A., et al.
Publicado: (2017)

Leishmanicidal Activity and Ultrastructural Changes of Maslinic Acid Isolated from Hyptidendron canum
por: Adriana Jesus, Jéssica, et al.
Publicado: (2021)

The Effect of Ursolic Acid on Leishmania (Leishmania) amazonensis Is Related to Programed Cell Death and Presents Therapeutic Potential in Experimental Cutaneous Leishmaniasis
por: Yamamoto, Eduardo S., et al.
Publicado: (2015)

High Selectivity of 8-Hydroxyquinoline on Leishmania (Leishmania) and Leishmania (Viannia) Species Correlates with a Potent Therapeutic Activity In Vivo
por: de Lima, Sarah Kymberly Santos, et al.
Publicado: (2023)

Repurposing Butenafine as An Oral Nanomedicine for Visceral Leishmaniasis
por: Bezerra-Souza, Adriana, et al.
Publicado: (2019)

Ethnopharmacology Study of Plants from Atlantic Forest with Leishmanicidal Activity
por: Santos, Beatriz Mendes, et al.
Publicado: (2019)

Nanoemulsified Butenafine for Enhanced Performance against Experimental Cutaneous Leishmaniasis
por: Bezerra-Souza, Adriana, et al.
Publicado: (2021)

Therapeutic Activity of a Topical Formulation Containing 8-Hydroxyquinoline for Cutaneous Leishmaniasis
por: de Lima, Sarah Kymberly Santos, et al.
Publicado: (2023)

Evaluation of Rhamnetin as an Inhibitor of the Pharmacological Effect of Secretory Phospholipase A2
por: Novo Belchor, Mariana, et al.
Publicado: (2017)

Dynamic of the Cellular Immune Response at the Dermal Site of Leishmania (L.) amazonensis and Leishmania (V.) braziliensis Infection in Sapajus apella Primate
por: Laurenti, Márcia Dalastra, et al.
Publicado: (2014)

In situ CUTANEOUS CELLULAR IMMUNE RESPONSE IN DOGS NATURALLY AFFECTED BY VISCERAL LEISHMANIASIS
por: ROSSI, Claudio Nazaretian, et al.
Publicado: (2016)

Serological and infection statuses of dogs from a visceral leishmaniasis-endemic area
por: Laranjeira, Daniela Farias, et al.
Publicado: (2014)

The Potential of Traditional Knowledge to Develop Effective Medicines for the Treatment of Leishmaniasis
por: Passero, Luiz Felipe D., et al.
Publicado: (2021)

Evaluating the Potential of Ursolic Acid as Bioproduct for Cutaneous and Visceral Leishmaniasis
por: Bilbao-Ramos, Pablo, et al.
Publicado: (2020)

Exposure to Leishmania spp. infection and Lutzomyia spp. in individuals living in an area endemic for visceral leishmaniasis in Brazil
por: Hirata, Karina Yukie, et al.
Publicado: (2019)

Evaluation of Regulatory Immune Response in Skin Lesions of Patients Affected by Nonulcerated or Atypical Cutaneous Leishmaniasis in Honduras, Central America
por: Araujo Flores, Gabriela Venicia, et al.
Publicado: (2018)

Further evidence associating IgG1, but not IgG2, with susceptibility to canine visceral leishmaniasis caused by Leishmania (L.) infantum chagasi-infection
por: Lima, Luciana Vieira do R., et al.
Publicado: (2017)

Reviewing the Etiologic Agents, Microbe-Host Relationship, Immune Response, Diagnosis, and Treatment in Chromoblastomycosis
por: Passero, Luiz Felipe Domingues, et al.
Publicado: (2021)

Correction: Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial
por: Lago, Jamile, et al.
Publicado: (2023)

Lymphocutaneous Sporotrichosis Refractory to First-Line Treatment
por: Belda, Walter, et al.
Publicado: (2021)

Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial
por: Lago, Jamile, et al.
Publicado: (2023)

Chromoblastomycosis evolving to sarcomatoid squamous cell carcinoma: A case report
por: Belda Junior, Walter, et al.
Publicado: (2021)

A case of tuberculosis verrucosa cutis in Brazil undiagnosed for 15 years
por: Wedy, Glaucia Ferreira, et al.
Publicado: (2021)

Effect of phospholipase A(2) inhibitors during infection caused by Leishmania (Leishmania) amazonensis
por: Bordon, Maria L. A. C., et al.
Publicado: (2018)

Ethoxycarbonylmethyl ursolate
por: Yang, Wei, et al.
Publicado: (2008)

Ursolic acid in health and disease
por: Seo, Dae Yun, et al.
Publicado: (2018)

Diabetes Modifies the Clinic Presentation of Cutaneous Leishmaniasis
por: Lago, Alexsandro S, et al.
Publicado: (2020)

Can domestic dogs be considered a good reservoir of Leishmania (L.) infantum chagasi in an endemic area of nonulcerated cutaneous leishmaniasis in Southern Honduras?
por: Segura, Gabriela Beatriz Rodriguez, et al.
Publicado: (2023)

Carboxymethyl ursolate monohydrate
por: Zhong, Yan, et al.
Publicado: (2011)

Comparative Genomic Analyses of New and Old World Viscerotropic Leishmanine Parasites: Further Insights into the Origins of Visceral Leishmaniasis Agents
por: Silveira, Fernando Tobias, et al.
Publicado: (2022)

Proteins of Leishmania (Viannia) shawi confer protection associated with Th1 immune response and memory generation
por: Passero, Luiz Felipe D, et al.
Publicado: (2012)

Leishmania enriettii visceralises in the trachea, lungs, and spleen of Cavia porcellus
por: Alves-Sobrinho, Ednéia Venâncio, et al.
Publicado: (2022)

Antibacterial and Antioxidant Activities of Ursolic Acid and Derivatives
por: do Nascimento, Patrícia G.G., et al.
Publicado: (2014)

Ursolic Acid and Its Derivatives as Bioactive Agents
por: Mlala, Sithenkosi, et al.
Publicado: (2019)

Antagonistic effect of ursolic acid on Staphylococcal biofilms
por: Jyothi, J. Shiva, et al.
Publicado: (2018)

Ursolic Acid Analogs as Potential Therapeutics for Cancer
por: Panda, Siva S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_471vdbln89886cai2r9t5374cv